A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics and Metabolism Study in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab Plus Ipilimumab in Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-986195 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Nivolumab in Selected Uterine Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Nivolumab in Recurrent and/or Metastatic SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1
To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)
- Status
- UNKNOWN
- Phase
- PHASE2
Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
- Status
- COMPLETED
- Phase
- PHASE3